Japan Medical Devices Views

Pages

KHK files Abstral NDA in Japan

Orexo's partner, Kyowa Hakko Kirin (KHK) has submitted an NDA in Japan for Abstral (fentanyl [KW-2246]) sublingual tablet, developed for the treatment of breakthrough cancer pain. The product has...

Read article ›
JPO issues patent covering DispersinB

The Japanese Patent Office (JPO) has issued Patent No. 5,073,169, entitled: "Compositions and Methods for Enzymatic Detachment of Bacterial and Fungal Biofilms", covering Kane Biotech's DispersinB...

Read article ›

Pages

Filter results

By Geography

By Sector

By Information Type